Author:
Roberts Reade B,Arteaga Carlos L,Threadgill David W
Subject
Cancer Research,Cell Biology,Oncology
Reference63 articles.
1. Renal failure associated with the use of celecoxib and rofecoxib;Ahmad;Drug Saf.,2002
2. Clinical Trial Design and End Points for Epidermal Growth Factor Receptor-targeted Therapies;Arteaga;Clin. Cancer Res.,2003
3. Cardiovascular thrombotic events and COX-2 inhibitors;Bannwarth;J. Rheumatol.,2003
4. Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types;Baselga;J. Clin. Oncol.,2002
5. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system;Britsch;Genes Dev.,1998
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献